Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- TRADING UPDATES: Harmony Energy plans raise; Kavango sets drill target
28 Sep 2022 - UK earnings, trading statements calendar - next 7 days
22 Sep 2022 - Angle notes Parsortix success in pelvic mass pilot study
12 Sep 2022 - TRADING UPDATES: Angle hails study find; Eqtec buys plant in France
20 Jul 2022 - Director dealings: Angle CEO, finance chief join capital raise
19 Jul 2022 - LONDON MARKET CLOSE: Stocks higher as US rate hikes fears calm
15 Jul 2022 - IN BRIEF: Angle raises GBP20 million to progress Parsortix
15 Jul 2022 - AIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise
15 Jul 2022
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
TRADING UPDATES: Harmony Energy plans raise; Kavango sets drill target
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Angle notes Parsortix success in pelvic mass pilot study
(Alliance News) - Angle PLC on Monday noted the publication of results from a clinical study undertaken with Wilmot Cancer Institute, at the Universit...
TRADING UPDATES: Angle hails study find; Eqtec buys plant in France
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Director dealings: Angle CEO, finance chief join capital raise
(Sharecast News) - Liquid biopsy specialist Angle had two entries on the list of director buys on Tuesday, after its chief executive and chief financi...
LONDON MARKET CLOSE: Stocks higher as US rate hikes fears calm
(Alliance News) - Stocks in London ended the week in the green after positive retail sales data from the US, easing fears over future US interest rate...
IN BRIEF: Angle raises GBP20 million to progress Parsortix
Angle PLC - Surrey, England-based medical diagnostics company - Raises GBP20.1 million via share placing, marginally above the GBP20.0 million it aime...
AIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Follow the stocks
